• Tests
• Systems
• Impact
• Education
• Support
• About Us

• Respiratory
• HAI & Other Infectious Diseases
• Blood Virology, Women's Health, & Sexual Health
• TB & Emerging Infectious Diseases
• Oncology & Human Genetics
• View Our Global Products

• Cepheid GeneXpert® Systems
• GeneXpert Software
• Cepheid Connectivity and Interface Capabilities

• Global Access
• Faster Access to Lab Quality Results
• Better Testing Everywhere
• Enhanced Antibiotic Stewardship
• Optimized Infection Prevention
• Improved Oncology Diagnostics
• Simplified Workflow and Connectivity
• Customized Testing for Your Institution
• Effective Patient Management
• Global Health Solutions
• Breast Cancer Technology

• Resources
• Diagnostics First
• Webinars
• Customer Stories
• Knowing MORE Matters

• Self-Service Support
• Safety Data Sheets
• Upload Instrument Data
• Contact Us
• IVDR Update
• Specimen Collection

• Mission and History
• Our Leadership
• Sustainability
• Compliance, Policies, and Reports
• Business Development Opportunities
• Meet the Cepheid Bike
• Distributors
• News
• Events
• Innovate with Cepheid
• Contact Us
• Careers

• Xpert® Xpress CoV-2 plus
• Xpert® Xpress CoV-2/Flu/RSV plus
• View Our Global Products

• Xpert® SA Nasal Complete
• Xpert® MRSA/SA Blood Culture
• View Our Global Products

• Resistance Plus ® MG FleXible
• Xpert® CT/NG
• View Our Global Products

• View Our Global Products

• View Our Global Products

• GeneXpert System
• GeneXpert Infinity

• GeneXpert Diagnostic Software
• Xpertise Software

• Cepheid C360
• GeneXpert Interface Capabilities

• Tuberculosis
• Eligibility & Pricing
• HIV

• PCR vs Antigen Tests
• Covid vs. Flu vs. RSV

• Environmental Sustainability
• Product Stewardship
• Conflict Minerals